P. Gimel

464 total citations
12 papers, 97 citations indexed

About

P. Gimel is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, P. Gimel has authored 12 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in P. Gimel's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (6 papers) and Renal and Vascular Pathologies (5 papers). P. Gimel is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (6 papers) and Renal and Vascular Pathologies (5 papers). P. Gimel collaborates with scholars based in France and India. P. Gimel's co-authors include Jean‐Christophe Bernhard, N. Costedoat‐Chalumeau, Idir Ouzaïd, Laurence Albigès, Christine Chevreau, Jean‐Laurent Deville, Christian Pfister, Frédéric Rolland, Marine Gross‐Goupil and Brigitte Laguerre and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

P. Gimel

10 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Gimel France 6 82 50 23 22 13 12 97
Ania Sliwinski Australia 7 103 1.3× 23 0.5× 32 1.4× 34 1.5× 6 0.5× 8 145
Michael Williamson Ireland 4 110 1.3× 38 0.8× 28 1.2× 35 1.6× 13 1.0× 6 161
James G. Dowty Australia 8 31 0.4× 59 1.2× 48 2.1× 40 1.8× 8 0.6× 18 161
Shingai B.A. Mutambirwa South Africa 6 47 0.6× 16 0.3× 30 1.3× 16 0.7× 8 0.6× 22 92
Chu Van Nguyen Vietnam 7 37 0.5× 20 0.4× 26 1.1× 62 2.8× 10 0.8× 36 114
David Queiroz Borges Muniz Brazil 6 53 0.6× 30 0.6× 14 0.6× 59 2.7× 17 1.3× 17 119
Jasnoor Malhotra United States 7 82 1.0× 51 1.0× 36 1.6× 69 3.1× 7 0.5× 26 138
L. Zhang China 7 54 0.7× 31 0.6× 7 0.3× 77 3.5× 16 1.2× 17 141
Cunchuan Wang China 7 51 0.6× 26 0.5× 21 0.9× 18 0.8× 12 0.9× 17 114
Eduardo Cronemberger Brazil 7 61 0.7× 14 0.3× 18 0.8× 48 2.2× 17 1.3× 15 94

Countries citing papers authored by P. Gimel

Since Specialization
Citations

This map shows the geographic impact of P. Gimel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gimel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gimel more than expected).

Fields of papers citing papers by P. Gimel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gimel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gimel. The network helps show where P. Gimel may publish in the future.

Co-authorship network of co-authors of P. Gimel

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gimel. A scholar is included among the top collaborators of P. Gimel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gimel. P. Gimel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bigot, Pierre, Philippe Barthélémy, Z. Khene, et al.. (2022). French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer. Progrès en Urologie. 32(15). 1195–1274. 14 indexed citations
2.
Gimel, P., et al.. (2020). Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis. European Journal of Clinical Microbiology & Infectious Diseases. 39(11). 2077–2083. 9 indexed citations
3.
Bensalah, Karim, Pierre Bigot, Laurence Albigès, et al.. (2020). Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein. Progrès en Urologie. 30(12). S2–S51. 13 indexed citations
4.
Bensalah, Karim, Laurence Albigès, Jean‐Christophe Bernhard, et al.. (2016). Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer du rein. Progrès en Urologie. 27. S27–S51. 15 indexed citations
5.
Oudard, Stéphane, Lionnel Geoffrois, Aline Guillot, et al.. (2016). Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study. European Journal of Cancer. 62. 28–35. 29 indexed citations
6.
Boissier, R., Pierre Bigot, Charles Dariane, et al.. (2016). Survie à long terme des tumeurs kystiques du rein–enquête du CCA-AFU. Progrès en Urologie. 26(13). 817–817.
7.
Oudard, Stéphane, M. Gross Goupil, L. Geoffrois, et al.. (2014). Clinical Activity of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma (Mrcc) – Results of the Resume Study. Annals of Oncology. 25. iv283–iv283. 6 indexed citations
8.
Robert, Caroline & P. Gimel. (2011). Gestion des effets secondaires des thérapies ciblées dans le cancer du rein : thérapies ciblées et effets secondaires dermatologiques. Bulletin du Cancer. 98(3). S35–S46. 2 indexed citations
9.
Lang, Hervé, et al.. (2003). [Extended total nephrectomy with laparoscopy in localized renal carcinoma. Report of 25 cases compared with 32 conventional surgical cases].. PubMed. 13(4). 569–76. 2 indexed citations
10.
Gimel, P., et al.. (2002). [Contribution of the latest generation CT in preoperative assessment of kidney cancer].. PubMed. 12(6). 1310–7. 4 indexed citations
11.
Blum, Alain, T Ludig, Deirdre M. Coll, et al.. (2002). [Preoperative evaluation of renal carcinoma using multi-detector CT].. PubMed. 83(4 Pt 1). 431–50. 2 indexed citations
12.
Hubert, Jacques, et al.. (2001). [Role of multiarray scanner in the choice of therapeutic strategy in kidney cancer. Report of a case of kidney tumor with double thrombus in inferior vena cava].. PubMed. 11(2). 296–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ania Sliwinski Breakdown of academic impact, for papers by Michael Williamson Breakdown of academic impact, for papers by James G. Dowty Breakdown of academic impact, for papers by Shingai B.A. Mutambirwa Breakdown of academic impact, for papers by Chu Van Nguyen Breakdown of academic impact, for papers by David Queiroz Borges Muniz Breakdown of academic impact, for papers by Jasnoor Malhotra Breakdown of academic impact, for papers by L. Zhang Breakdown of academic impact, for papers by Cunchuan Wang Breakdown of academic impact, for papers by Eduardo Cronemberger
Rankless by CCL
2026